2026-04-16
On 15 April 2026, we celebrated the stock market debut of Syn2bio, a biotechnology company spun off from Synektik, which has been listed on the Warsaw Stock Exchange (WSE) for more than a decade.
2025-04-15
We’re excited to announce that Beata Krowicka-Makowska and Jan Pakuła have been appointed Project Directors.